The CRUK CoL Centre training programme is a cross-disciplinary and collaborative initiative for basic and clinical researchers who are interested in carrying out PhD projects based in cancer biotherapeutics.
The programme offers bespoke, high quality scientific & transferable skills training, harnessing the breadth and depth of resources and knowledge across the Centre. Students will participate in an induction week, multi-disciplinary training, cross-institutional research placements and cohort-building activities, including participation in the Centre’s networking workshops and conferences. Moreover, trainees on the programme will benefit from an exciting academic environment underpinned by world-class technical expertise provided via the Centre’s research programmes and infrastructure cores.
In September 2019 our first cohort of clinical fellows and PhD students commenced their PhDs. To find out more about them and their projects, please visit the current students page.
2020 Key Dates
2020 /2021 CoL Centre Training Programme start date – 28 September 2020
CoL RadNet students will follow the CRUK CoL Centre PhD training programme. In addition to carrying out their PhD research and participating in core mandatory activities, each trainee will have a ‘customised’ training programme, which will be developed with their supervisors taking into account the trainee’s background and PhD project needs.
Applications for 2021 RadNet PhD studentships will open in October.
The CRUK CoL Centre will also award MBPhD studentships as part of the UCL MBPhD programme starting in September 2020. This is a unique opportunity for talented and exceptional MBBS students who have an interest in cancer research to kick start their clinical academic career.
Applications for MBPhD studentships will open in November.
Aimed at clinicians who wish to undertake PhD research training. Applications for 2021 fellowships will open in October.
Applications for an AstraZeneca Clinical Research Training Fellowship starting in Jan 2021 are now closed.